NEWS
DarioHealth partners with MediOrbis on virtual diabetes care platform

DarioHealth (NSDQ:DRIO) announced that it launched a new virtual care initiative with MediOrbis to improve virtual care for diabetes. New York-based DarioHealth’s collaboration with MediOrbis is slated to offer eligible Medicare members with diabetes a convenient method for virtual care that includes MediOrbis’ telehealth offerings and DarioHealth’s AI-powered remote patient monitoring, according to a news […]

Ver­tex adds a new gene edit­ing part­ner, pay­ing Ob­sid­i­an $75M cash for con­trol­lable CRISPR sys­tem
| Endpoints News

When Paul Wotton became CEO of Obsidian Therapeutics two years ago, he asked his team to explore where they could apply the company’s technology beyond cancer. Launched by Michael Gilman in 2017, the GV-backed company had been working on a way of controlling cell therapies after they’re administered to a patient, allowing doctors to modulate […]

Two companies partner on telehealth, remote patient monitoring initiative for older diabetics

A new initiative between MediOrbis, a telehealth provider specializing in chronic conditions, and DarioHealth Corp., a digital therapeutics company, offers older diabetics telehealth and remote patient monitoring. The program is geared to eligible Medicare beneficiaries. Initially accessing the new virtual care program will be Dario’s approximately 75,000 members with diabetes — of which 30% are […]